Biomarker Research for Personalized Medicine

Biomarker Research for Personalized Medicine in Blood Cancer Patient

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01488591

Enrollment

1000

Registered

2011-12-08

Start date

2009-04-30

Completion date

Unknown

Last updated

2013-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematologic Neoplasms

Brief summary

The aim of this study : 1. Through the study of genes of protein, transporter, translator and epigenome investigating the effect of anti-cancer treatment or the key factor of the MDR (Multidrug resistance) on the blood cancer patients who are under the anti-cancer sork treatment 2. Giving a service of anticancer medicine therapeutic drug monitoring (TDM) and genotyping

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Korean * Clinical diagnosis of Hematologic neoplasms

Countries

South Korea

Contacts

Primary ContactJae Gook Shin, M.D.,Ph.D.

phshinjg@inje.ac.kr82-51-890-6709

Outcome results